COX-2 contributed to the remifentanil-induced hyperalgesia related to ephrinB/EphB signaling

References

• Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006;104:570–587.
   PubMed Web of Science ®Google Scholar
• Chen L, Malarick C, Seefeld L, et al. Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain. 2009;143:65–70.
   PubMed Web of Science ®Google Scholar
• Egan TD, Lemmens HJ, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology. 1993;79:881–892.
   PubMed Web of Science ®Google Scholar
• Celerier E, Rivat C, Jun Y, et al. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology. 2000;92:465–472.
   PubMed Web of Science ®Google Scholar
• Derrode N, Lebrun F, Levron JC, et al. Influence of peroperative opioid on postoperative pain after major abdominal surgery: sufentanil TCI versus remifentanil TCI. A randomized, controlled study. Br J Anaesth. 2003;91:842–849.
   PubMed Web of Science ®Google Scholar
• Ma JF, Huang ZL, Li J, et al. Cohort study of remifentanil-induced hyperalgesia in postoperative patients. Zhonghua yi xue za zhi. 2011;91:977–979.
   PubMedGoogle Scholar
• Xia WS, Peng YN, Tang LH, et al. Spinal ephrinB/EphB signalling contributed to remifentanil-induced hyperalgesia via NMDA receptor. Eur J pain. 2014;18:1231–1239.
   PubMed Web of Science ®Google Scholar
• Feldman PL, James MK, Brackeen MF, et al. Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics. J Med Chem. 1991;34:2202–2208.
   PubMed Web of Science ®Google Scholar
• Thompson JP, Rowbotham DJ. Remifentanil–an opioid for the 21st century. Br J Anaesth. 1996;76:341–343.
   PubMed Web of Science ®Google Scholar
• Trescot AM, Datta S, Lee M, et al. Opioid pharmacology. Pain Physician. 2008;11:S133–S153.
   PubMed Web of Science ®Google Scholar
• Drdla R, Gassner M, Gingl E, et al. Induction of synaptic long-term potentiation after opioid withdrawal. Science. 2009;325:207–210.
   PubMed Web of Science ®Google Scholar
• Koppert W, Sittl R, Scheuber K, et al. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology. 2003;99:152–159.
   PubMed Web of Science ®Google Scholar
• Rivat C, Laulin JP, Corcuff JB, et al. Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology. 2002;96:381–391.
   PubMed Web of Science ®Google Scholar
• Song XJ, Zheng JH, Cao JL, et al. EphrinB-EphB receptor signaling contributes to neuropathic pain by regulating neural excitability and spinal synaptic plasticity in rats. Pain. 2008;139:168–180.
   PubMed Web of Science ®Google Scholar
• Ruan JP, Zhang HX, Lu XF, et al. EphrinBs/EphBs signaling is involved in modulation of spinal nociceptive processing through a mitogen-activated protein kinases-dependent mechanism. Anesthesiology. 2010;112:1234–1249.
   PubMed Web of Science ®Google Scholar
• Lenz H, Raeder J, Draegni T, et al. Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans. Pain. 2011;152:1289–1297.
   PubMed Web of Science ®Google Scholar
• Troster A, Sittl R, Singler B, et al. Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology. 2006;105:1016–1023.
   PubMed Web of Science ®Google Scholar
• Bezzi P, Carmignoto G, Pasti L, et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature. 1998;391:281–285.
   PubMed Web of Science ®Google Scholar
• O’Rielly DD, Loomis CW. Increased expression of cyclooxygenase and nitric oxide isoforms, and exaggerated sensitivity to prostaglandin E2, in the rat lumbar spinal cord 3 days after L5-L6 spinal nerve ligation. Anesthesiology. 2006;104:328–337.
   PubMed Web of Science ®Google Scholar
• Malmberg AB, Yaksh TL. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science. 1992;257:1276–1279.
   PubMed Web of Science ®Google Scholar
• Yu LN, Zhou XL, Yu J, et al. PI3K contributed to modulation of spinal nociceptive information related to ephrinBs/EphBs. PloS one. 2012;7:e40930.
   PubMed Web of Science ®Google Scholar
• Ji RR, Strichartz G. Cell signaling and the genesis of neuropathic pain. Sci STKE. 2004;2004:reE14.
   PubMedGoogle Scholar
• Simonetti M, Hagenston AM, Vardeh D, et al. Nuclear calcium signaling in spinal neurons drives a genomic program required for persistent inflammatory pain. Neuron. 2013;77:43–57.
   PubMed Web of Science ®Google Scholar
• Karim F, Wang CC, Gereau R. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci. 2001;21:3771–3779.
   PubMed Web of Science ®Google Scholar
• Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001;410:471–475.
   PubMed Web of Science ®Google Scholar
• Seybold VS, Jia YP, Abrahams LG. Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation. Pain. 2003;105:47–55.
   PubMed Web of Science ®Google Scholar
• Zhou XL, Wang Y, Zhang CJ, et al. COX-2 is required for the modulation of spinal nociceptive information related to ephrinB/EphB signalling. Eur J pain. 2015;19:1277–1287.
   PubMed Web of Science ®Google Scholar
• Craft RM. Modulation of pain by estrogens. Pain. 2007;132(Suppl 1):S3–S12.
   PubMedGoogle Scholar
• Mestre C, Pelissier T, Fialip J, et al. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods. 1994;32:197–200.
   PubMed Web of Science ®Google Scholar
• Criado AB, Gomez E Segura IA. Reduction of isoflurane MAC by fentanyl or remifentanil in rats. Vet Anaesth Analg. 2003;30:250–256.
   PubMed Web of Science ®Google Scholar
• Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain. 1996;64:493–501.
   PubMed Web of Science ®Google Scholar
• Celerier E, Gonzalez JR, Maldonado R, et al. Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide synthase. Anesthesiology. 2006;104:546–555.
   PubMed Web of Science ®Google Scholar
• Cabanero D, Celerier E, Garcia-Nogales P, et al. The pro-nociceptive effects of remifentanil or surgical injury in mice are associated with a decrease in delta-opioid receptor mRNA levels: prevention of the nociceptive response by on-site delivery of enkephalins. Pain. 2009;141:88–96.
   PubMed Web of Science ®Google Scholar
• Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88.
   PubMed Web of Science ®Google Scholar
• Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55–63.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain. 2006;7:43–48.
   PubMed Web of Science ®Google Scholar
• Dalva MB, Takasu MA, Lin MZ, et al. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell. 2000;103:945–956.
   PubMed Web of Science ®Google Scholar
• Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24:479–496.
   PubMed Web of Science ®Google Scholar
• Ji RR, Baba H, Brenner GJ, et al. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci. 1999;2:1114–1119.
   PubMed Web of Science ®Google Scholar
• Obata K, Yamanaka H, Dai Y, et al. Differential activation of extracellular signal-regulated protein kinase in primary afferent neurons regulates brain-derived neurotrophic factor expression after peripheral inflammation and nerve injury. J Neurosci. 2003;23:4117–4126.
   PubMed Web of Science ®Google Scholar
• Amaya F, Samad TA, Barrett L, et al. Periganglionic inflammation elicits a distally radiating pain hypersensitivity by promoting COX-2 induction in the dorsal root ganglion. Pain. 2009;142:59–67.
   PubMed Web of Science ®Google Scholar
• Buvanendran A, Kroin JS, Berger RA, et al. Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology. 2006;104:403–410.
   PubMed Web of Science ®Google Scholar
• Kohno T, Wang H, Amaya F, et al. Bradykinin enhances AMPA and NMDA receptor activity in spinal cord dorsal horn neurons by activating multiple kinases to produce pain hypersensitivity. J Neurosci. 2008;28:4533–4540.
   PubMed Web of Science ®Google Scholar
• Ahmadi S, Lippross S, Neuhuber WL, et al. PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nat Neurosci. 2002;5:34–40.
   PubMed Web of Science ®Google Scholar
• Harvey RJ, Depner UB, Wassle H, et al. GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science. 2004;304:884–887.
   PubMed Web of Science ®Google Scholar
• Cao DL, Zhang ZJ, Xie RG, et al. Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2. Exp Neurol. 2014;261:328–336.
   PubMed Web of Science ®Google Scholar
• Guo YJ, Shi XD, Fu D, et al. Analgesic effects of the COX-2 inhibitor parecoxib on surgical pain through suppression of spinal ERK signaling. Exp Ther Med. 2013;6:275–279.
   PubMed Web of Science ®Google Scholar
• Zhao P, Waxman SG, Hains BC. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J Neurosci. 2007;27:2357–2368.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xin X, Dong Y, et al. Surgical incision-induced nociception causes cognitive impairment and reduction in synaptic NMDA receptor 2B in mice. J Neurosci. 2013;33:17737–17748.
   PubMed Web of Science ®Google Scholar
• Rivat C, Richebe P, Laboureyras E, et al. Polyamine deficient diet to relieve pain hypersensitivity. Pain. 2008;137:125–137.
   PubMed Web of Science ®Google Scholar